We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Dr. Reddy’s Cuts Deal With End Payers in Broader Nexium Pay-for-Delay Lawsuit
Dr. Reddy’s Cuts Deal With End Payers in Broader Nexium Pay-for-Delay Lawsuit
Dr. Reddy’s Laboratories has settled a class-action lawsuit over its alleged role in delaying generic entry of AstraZeneca’s heartburn drug Nexium in return for assisting plaintiffs in their case against AZ and the remaining generics manufacturer defendants.